Emmanuel Stip psychiatre canadien
Stip, Emmanuel
VIAF ID: 282853158 (Personal)
Permalink: http://viaf.org/viaf/282853158
Preferred Forms
- 100 0 _ ‡a Emmanuel Stip ‡c psychiatre canadien
-
- 100 1 _ ‡a Stip, Emmanuel
- 100 1 _ ‡a Stip, Emmanuel
4xx's: Alternate Name Forms (5)
Works
Title | Sources |
---|---|
Développement d'assistants technologiques cognitifs pour la schizophrénie : favoriser l’autonomie et l’adhésion au traitement | |
Facing Confinement, the Comfort of WhatsApp Groups in Mental Health Communities | |
Health care resource use associated with integrated psychological treatment. | |
[History of the department of Psychiatry at the University of Montreal]. | |
[Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives] | |
L’implantation au Québec de l’Integrated Psychological Treatment (IPT) auprès des personnes atteintes de schizophrénie : cinq ans après | |
Increased ventro-medial prefrontal activations in schizophrenia smokers during cigarette cravings. | |
Interface santé mentale, société et toxicomanie – une thématique et deux illustrations : l’usage médical du cannabis et le hikikomori | |
Intrusion errors in explicit memory: their differential relationship with clinical and social outcome in chronic schizophrenia. | |
[Kitchen and schizophrenia: a crossroad activity of an ecological, occupational and neuropsychological assessment]. | |
Maintenant qu’elle est bien découverte, la psychothérapie devrait être couverte ! | |
Markedly Reduced Thermal Pain Perception in a Schizoaffective Patient with Tardive Dyskinesia | |
Multisite generalizability of schizophrenia diagnosis classification based on functional brain connectivity | |
Mutations associated with neuropsychiatric conditions delineate functional brain connectivity dimensions contributing to autism and schizophrenia | |
Neural changes associated with appetite information processing in schizophrenic patients after 16 weeks of olanzapine treatment | |
Neural correlates of emotional recognition memory in schizophrenia: effects of valence and arousal | |
The neural correlates of mental rotation abilities in cannabis-abusing patients with schizophrenia: an FMRI study | |
Neurobiology of severe mental disorders: from cell to bedside 25th International Symposium of the Centre de recherche en sciences neurologiques, Université de Montréal | |
[Neurocognitive insight in schizophrenia: a meta-analysis]. | |
A neuroimaging study of emotion-cognition interaction in schizophrenia: the effect of ziprasidone treatment | |
Oral cholinesterase inhibitor add-on therapy for cognitive enhancement in schizophrenia: a quantitative systematic review, Part I. | |
Oral versus Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Special Populations at Risk for Treatment Nonadherence: A Systematic Review | |
Le packing avec les enfants autistes et psychotiques, par Pierre Delion, Érès 1998. | |
Pain perception in schizophrenia: evidence of a specific pain response profile. | |
Pain perception in schizophrenia: no changes in diffuse noxious inhibitory controls (DNIC) but a lack of pain sensitization. | |
The paradox of quetiapine in obsessive-compulsive disorder. | |
Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the "Mirror Effect" of Schizophrenia | |
Predictors of quality of life in schizophrenia. | |
Preserved awareness of their cognitive deficits in patients with schizophrenia: convergent validity of the SSTICS. | |
La psychiatrie sans influence : schizoanalyse au bord de la fenêtre | |
Psychiatry and COVID-19: The Role of Chlorpromazine | |
Psychopathologie et bases neurobiologiques des hallucinations auditives dans la schizophrénie | |
Quetiapine blocks cocaine-induced enhancement of brain stimulation reward | |
Quetiapine: focus on emotional numbing in depersonalization disorder: an fMRI case report | |
[RaeRae and Mahu: third polynesian gender]. | |
A randomized controlled trial with a Canadian electronic pill dispenser used to measure and improve medication adherence in patients with schizophrenia | |
Redevelopment of tertiary psychiatric services in British Columbia: a prospective study of clinical, social, and residential outcomes of former long-stay inpatients. | |
Relationships between Brain Structure and Metabolic Changes in Schizophrenia Patients Treated with Olanzapine: A Voxel-Based Morphometric Study | |
The relationships between cognition and psychosocial functioning in schizophrenia. | |
Restoration of frontal activation during a treatment with quetiapine: an fMRI study of blunted affect in schizophrenia | |
Retour à l’école de jeunes patients souffrant de troubles mentaux graves : premier regard sur un projet pilote montréalais | |
Le rôle du soutien social, du fardeau familial et de la satisfaction des services dans la détresse psychologique et la qualité de vie des familles de personnes souffrant de schizophrénie | |
Rôles des médecins de famille dans le traitement des troubles psychotiques | |
Santé mentale des populations : un court fleuve tranquille. | |
[Schizophrenia and addiction: An evaluation of the self-medication hypothesis] | |
Schizophrénie et toxicomanie : l’héritage du psychiatre Jean-Yves Roy | |
SCLEROSE EN PLAQUES : L'HYPOTHESE PSYCHOSOMATIQUE; ESSAI DE VALIDATION A PROPOS D'UNE ETUDE CONTROLEE DE 35 CAS | |
The screen for cognitive impairment in psychiatry (SCIP) is associated with disease severity and cognitive complaints in major depression. | |
Selective Serotonin Reuptake Inhibitor (SSRI) Add-On Therapy for the Negative Symptoms of Schizophrenia | |
Sex, age, symptoms and illness duration and their relation with gyrification index in schizophrenia. | |
Sex differences in the cerebral function associated with processing of aversive stimuli by schizophrenia patients. | |
Sex, sadness and schizophrenia: correlations between negative symptoms and cerebral activations | |
Sexual dimorphism of spatial working memory profiles in schizophrenia. | |
Should we treat auditory hallucinations with repetitive transcranial magnetic stimulation? A metaanalysis | |
Sleep architecture and its clinical correlates in first episode and neuroleptic-naive patients with schizophrenia. | |
Sleep habits in middle-aged, non-hospitalized men and women with schizophrenia: a comparison with healthy controls. | |
Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders | |
Subjective and Objective Cognitive Dysfunction in Schizophrenia - is there a Link? | |
Suicidal Ideation and Schizophrenia: Contribution of Appraisal, Stigmatization, and Cognition. | |
Sur la première ligne : sondage pour un partage. Les omnipraticiens et la schizophrénie | |
Switching from conventional antipsychotics to ziprasidone: a randomized, open-label comparison of regimen strategies | |
Toward a Meta-Analytic Approach of Sex Differences in Episodic Memory of Schizophrenia Patients: Exploratory Findings | |
Le traitement du trouble délirant et ses aspects cognitifs | |
Transitions | |
vin et la psychiatrie | |
Working memory and depressive symptoms in patients with schizophrenia and substance use disorders. | |
Ziprasidone for psychotic disorders: a meta-analysis and systematic review of the relationship between pharmacokinetics, pharmacodynamics, and clinical profile |